Management of atrial fibrillation in COVID-19 pandemic

Yu Feng Hu; Wen Han Cheng; Yuan Hung; Wen Yu Lin; Tze Fan Chao; Jo Nan Liao; Yenn Jiang Lin; Wei Shiang Lin; Yi Jen Chen; Shih Ann Chen

doi:10.1253/circj.CJ-20-0566

Management of atrial fibrillation in COVID-19 pandemic

Yu Feng Hu, Wen Han Cheng, Yuan Hung, Wen Yu Lin, Tze Fan Chao, Jo Nan Liao, Yenn Jiang Lin, Wei Shiang Lin, Yi Jen Chen, Shih Ann Chen^*

^*此作品的通信作者

醫學系內科學科

研究成果: Review article › 同行評審

17 引文斯高帕斯（Scopus）

摘要

The health crisis due to coronavirus disease 2019 (COVID-19) has shocked the world, with more than 1 million infections and casualties. COVID-19 can present from mild illness to multi-organ involvement, but especially acute respiratory distress syndrome. Cardiac injury and arrhythmias, including atrial fibrillation (AF), are not uncommon in COVID-19. COVID-19 is highly contagious, and therapy against the virus remains premature and largely unknown, which makes the management of AF patients during the pandemic particularly challenging. We describe a possible pathophysiological link between COVID-19 and AF, and therapeutic considerations for AF patients during this pandemic.

原文	English
頁（從 - 到）	1679-1685
頁數	7
期刊	Circulation Journal
卷	84
發行號	10
DOIs	https://doi.org/10.1253/circj.CJ-20-0566
出版狀態	Published - 25 9月 2020

存取文件

10.1253/circj.CJ-20-0566

其它文件與鏈接

Link to publication in Scopus

引用此

@article{3710bf391eb64aed94f068f0ef6f0e0f,

title = "Management of atrial fibrillation in COVID-19 pandemic",

abstract = "The health crisis due to coronavirus disease 2019 (COVID-19) has shocked the world, with more than 1 million infections and casualties. COVID-19 can present from mild illness to multi-organ involvement, but especially acute respiratory distress syndrome. Cardiac injury and arrhythmias, including atrial fibrillation (AF), are not uncommon in COVID-19. COVID-19 is highly contagious, and therapy against the virus remains premature and largely unknown, which makes the management of AF patients during the pandemic particularly challenging. We describe a possible pathophysiological link between COVID-19 and AF, and therapeutic considerations for AF patients during this pandemic.",

keywords = "Ablation, Antiarrhythmic drugs, Atrial fibrillation, Oral anticoagulation",

author = "Hu, {Yu Feng} and Cheng, {Wen Han} and Yuan Hung and Lin, {Wen Yu} and Chao, {Tze Fan} and Liao, {Jo Nan} and Lin, {Yenn Jiang} and Lin, {Wei Shiang} and Chen, {Yi Jen} and Chen, {Shih Ann}",

year = "2020",

month = sep,

day = "25",

doi = "10.1253/circj.CJ-20-0566",

language = "English",

volume = "84",

pages = "1679--1685",

journal = "Circulation Journal",

issn = "1346-9843",

publisher = "Japanese Circulation Society",

number = "10",

}

TY - JOUR

T1 - Management of atrial fibrillation in COVID-19 pandemic

AU - Hu, Yu Feng

AU - Cheng, Wen Han

AU - Hung, Yuan

AU - Lin, Wen Yu

AU - Chao, Tze Fan

AU - Liao, Jo Nan

AU - Lin, Yenn Jiang

AU - Lin, Wei Shiang

AU - Chen, Yi Jen

AU - Chen, Shih Ann

PY - 2020/9/25

Y1 - 2020/9/25

N2 - The health crisis due to coronavirus disease 2019 (COVID-19) has shocked the world, with more than 1 million infections and casualties. COVID-19 can present from mild illness to multi-organ involvement, but especially acute respiratory distress syndrome. Cardiac injury and arrhythmias, including atrial fibrillation (AF), are not uncommon in COVID-19. COVID-19 is highly contagious, and therapy against the virus remains premature and largely unknown, which makes the management of AF patients during the pandemic particularly challenging. We describe a possible pathophysiological link between COVID-19 and AF, and therapeutic considerations for AF patients during this pandemic.

AB - The health crisis due to coronavirus disease 2019 (COVID-19) has shocked the world, with more than 1 million infections and casualties. COVID-19 can present from mild illness to multi-organ involvement, but especially acute respiratory distress syndrome. Cardiac injury and arrhythmias, including atrial fibrillation (AF), are not uncommon in COVID-19. COVID-19 is highly contagious, and therapy against the virus remains premature and largely unknown, which makes the management of AF patients during the pandemic particularly challenging. We describe a possible pathophysiological link between COVID-19 and AF, and therapeutic considerations for AF patients during this pandemic.

KW - Ablation

KW - Antiarrhythmic drugs

KW - Atrial fibrillation

KW - Oral anticoagulation

UR - http://www.scopus.com/inward/record.url?scp=85091808965&partnerID=8YFLogxK

U2 - 10.1253/circj.CJ-20-0566

DO - 10.1253/circj.CJ-20-0566

M3 - Review article

C2 - 32908073

AN - SCOPUS:85091808965

SN - 1346-9843

VL - 84

SP - 1679

EP - 1685

JO - Circulation Journal

JF - Circulation Journal

IS - 10

ER -

Management of atrial fibrillation in COVID-19 pandemic

摘要

存取文件

其它文件與鏈接

指紋

引用此